Haoxi Health Technology Limited Class A Ordinary Shares is an innovative leader in the health technology sector, dedicated to transforming healthcare delivery through cutting-edge solutions. By leveraging advanced technologies such as artificial intelligence and data analytics, the company enhances diagnostic accuracy, treatment efficiency, and overall patient management. With a strong commitment to research and development, Haoxi is strategically positioned to harness emerging trends in healthcare technology, offering substantial growth potential for institutional investors seeking to capitalize on the evolving landscape.
| Revenue (TTM) | $42.68M |
| Gross Profit (TTM) | $2.04M |
| EBITDA | $-7.05M |
| Operating Margin | -16.80% |
| Return on Equity | -16.00% |
| Return on Assets | -22.10% |
| Revenue/Share (TTM) | $9.40 |
| Book Value | $0.27 |
| Price-to-Book | 2.76 |
| Price-to-Sales (TTM) | 0.99 |
| EV/Revenue | 0.909 |
| EV/EBITDA | 13.53 |
| Quarterly Earnings Growth (YoY) | 172.70% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | $58.75M |
| Float | $58.29M |
| % Insiders | 0.73% |
| % Institutions | 0.07% |
Volatility is currently expanding